Pinnacle Research Group | Anniston, AL
Status and phase
Conditions
Treatments
About
This study includes 3 parts: Parts A, B, and C. The purpose of this study is to evaluate the immunogenicity and safety of mRNA-1010 seasonal influenza vaccine in adults.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Part A:
Part B:
Part C:
Exclusion criteria
Note: Other inclusion and exclusion criteria may apply.
Primary purpose
Allocation
Interventional model
Masking
8,422 participants in 2 patient groups
Loading...
Central trial contact
Moderna Clinical Trials Support Center
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal